Drug makers nervous on stricter rebate rules

Pharmaceutical companies are concerned over the government's move to strictly apply regulations on rebates.

Health authorities are sending warning signals to drug makers that cut the prices of drugs in question by 20 percent, starting this month, if the makers violate the self-imposed agreement.

Concern in the local pharmaceutical industry was fuelled recently as the discovery of illegal...